| β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein B Moya, A Dötsch, C Juan, J Blázquez, L Zamorano, S Haussler, A Oliver PLoS pathogens 5 (3), e1000353, 2009 | 324 | 2009 |
| Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones G Cabot, AA Ocampo-Sosa, MA Domínguez, JF Gago, C Juan, F Tubau, ... Antimicrobial agents and chemotherapy 56 (12), 6349-6357, 2012 | 251* | 2012 |
| Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study G Cabot, AA Ocampo-Sosa, F Tubau, MD Macia, C Rodríguez, B Moya, ... Antimicrobial agents and chemotherapy 55 (5), 1906-1911, 2011 | 240 | 2011 |
| Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC G Cabot, S Bruchmann, X Mulet, L Zamorano, B Moyà, C Juan, ... Antimicrobial agents and chemotherapy 58 (6), 3091-3099, 2014 | 238 | 2014 |
| Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates G Cabot, L Zamorano, B Moyà, C Juan, A Navas, J Blázquez, A Oliver Antimicrobial agents and chemotherapy 60 (3), 1767-1778, 2016 | 220 | 2016 |
| Influence of Virulence Genotype and Resistance Profile in the Mortality of Pseudomonas aeruginosa Bloodstream Infections C Peña, G Cabot, S Gómez-Zorrilla, L Zamorano, A Ocampo-Sosa, ... Clinical Infectious Diseases 60 (4), 539-548, 2015 | 214 | 2015 |
| Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities B Moyá, A Beceiro, G Cabot, C Juan, L Zamorano, S Alberti, A Oliver Antimicrobial agents and chemotherapy 56 (9), 4771-4778, 2012 | 176 | 2012 |
| Prospective Multicenter Study of Carbapenemase-Producing Enterobacteriaceae from 83 Hospitals in Spain Reveals High In Vitro Susceptibility to Colistin and … J Oteo, A Ortega, R Bartolomé, G Bou, C Conejo, M Fernández-Martínez, ... Antimicrobial Agents and Chemotherapy 59 (6), 3406-3412, 2015 | 168 | 2015 |
| Genomics and susceptibility profiles of extensively drug-resistant Pseudomonas aeruginosa isolates from Spain E del Barrio-Tofiño, C López-Causapé, G Cabot, A Rivera, N Benito, ... Antimicrobial agents and chemotherapy 61 (11), 10.1128/aac. 01589-17, 2017 | 155 | 2017 |
| Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain E Miró, J Agüero, MN Larrosa, A Fernández, MC Conejo, G Bou, ... European journal of clinical microbiology & infectious diseases 32, 253-259, 2013 | 145 | 2013 |
| Biological markers of Pseudomonas aeruginosa epidemic high-risk clones X Mulet, G Cabot, AA Ocampo-Sosa, MA Domínguez, L Zamorano, ... Antimicrobial agents and chemotherapy 57 (11), 5527-5535, 2013 | 143 | 2013 |
| Alterations of OprD in carbapenem-intermediate and-susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study AA Ocampo-Sosa, G Cabot, C Rodríguez, E Roman, F Tubau, MD Macia, ... Antimicrobial agents and chemotherapy 56 (4), 1703-1713, 2012 | 140 | 2012 |
| Metallo-β-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones C Juan, L Zamorano, A Mena, S Albertí, JL Pérez, A Oliver Journal of antimicrobial chemotherapy 65 (3), 474-478, 2010 | 135 | 2010 |
| Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 Pseudomonas aeruginosa Isolates Producing the Extended-Spectrum β-Lactamases GES-1 … E Viedma, C Juan, J Acosta, L Zamorano, JR Otero, F Sanz, F Chaves, ... Antimicrobial agents and chemotherapy 53 (11), 4930-4933, 2009 | 134 | 2009 |
| Activity of a New Cephalosporin, CXA-101 (FR264205), against β-Lactam-Resistant Pseudomonas aeruginosa Mutants Selected In Vitro and after … B Moya, L Zamorano, C Juan, JL Pérez, Y Ge, A Oliver Antimicrobial agents and chemotherapy 54 (3), 1213-1217, 2010 | 129 | 2010 |
| Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins of Pseudomonas aeruginosa B Moyá, L Zamorano, C Juan, Y Ge, A Oliver Antimicrobial agents and chemotherapy 54 (9), 3933-3937, 2010 | 123 | 2010 |
| Deciphering the resistome of the widespread Pseudomonas aeruginosa sequence type 175 international high-risk clone through whole-genome sequencing G Cabot, C López-Causapé, AA Ocampo-Sosa, LM Sommer, ... Antimicrobial agents and chemotherapy 60 (12), 7415-7423, 2016 | 121 | 2016 |
| Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology E del Barrio-Tofiño, L Zamorano, S Cortes-Lara, C López-Causapé, ... Journal of Antimicrobial Chemotherapy 74 (7), 1825-1835, 2019 | 111 | 2019 |
| Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains C Juan, L Zamorano, JL Pérez, Y Ge, A Oliver Antimicrobial agents and chemotherapy 54 (2), 846-851, 2010 | 109 | 2010 |
| Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain ZR Palacios-Baena, J Oteo, C Conejo, MN Larrosa, G Bou, ... Journal of Infection 72 (2), 152-160, 2016 | 95 | 2016 |
